HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LXT-101

structure in first source

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - LXT-101: 5

Experts

1.	Gao, Lijun: 2 articles (06/2013 - 07/2011)
2.	Quan, Dongqin: 2 articles (06/2013 - 07/2011)
3.	Wang, Tao: 2 articles (06/2013 - 07/2011)
4.	Du, Lina: 2 articles (03/2011 - 09/2006)
5.	Mei, Xingguo: 2 articles (03/2011 - 09/2006)
6.	Cheng, Junping: 2 articles (09/2006 - 09/2006)
7.	Zhang, Guiying: 1 article (06/2013)
8.	Jin, Yiguang: 1 article (03/2011)
9.	Li, Xin: 1 article (03/2011)
10.	Wang, Chenyun: 1 article (03/2011)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 06/25/2013 - "LXT-101, a cationic peptide is a novel antagonist of gonadotropin-releasing hormone (GnRH) for prostate cancer treatment. " 07/01/2011 - "LXT-101, a cationic amphipathic peptide, is a novel antagonist of gonadotropin-releasing hormone (GnRH) for prostate cancer treatment. " 09/01/2006 - "A sustained release poly(DL-lactide-co-glycolide) (PLGA) microsphere delivery system to treat prostate cancer for a luteinizing hormone-releasing hormone (LHRH) antagonists, LXT-101 was prepared and evaluated in the paper. "
2.	Neoplasms (Cancer) 03/01/2011 - "The LXT-101 microspheres could be a promising drug delivery system candidate to treat sex hormone-dependent tumors and other related disorders." 09/11/2006 - "These results indicated that LXT-101 is fit for sustained-release formulation and it might possibly be developed as an ideal candidate for treating sex hormone-sensitive tumors and other disorders."

Related Drugs and Biologics

1.	Gonadotropin-Releasing Hormone (GnRH)
2.	Gonadal Steroid Hormones (Sex Hormones)
3.	Peptides (Polypeptides)
4.	Delayed-Action Preparations
5.	poly(lactide) (polylactic acid)

Related Therapies and Procedures

1.	Microspheres (Microsphere)